Thomson Reuters Corp (TRI.TO) Buy, Sell or Hold

Home

Daily Stock Opinions and Ratings

Thomson Reuters Corp (TRI.TO)

146.24

-7.73 (5.02%)

as of Sep 4, 2026, 8:00:00 pm Market Open.

221 watching

Investor Insights

Sep 4, 2026, 12:00 am

This summary was created by AI, based on 36 opinions in the last 12 months.

Thomson Reuters Corp (TRI) is currently facing significant market skepticism regarding the potential impact of artificial intelligence (AI) on its core legal and financial data services. Despite fears that AI might replace critical aspects of its services, many analysts argue that TRI's extensive proprietary data gives it a strong competitive advantage that will persist in the long term. The company recently showed solid financial performance, including stable topline growth, a significant free cash flow increase, and ongoing share buybacks. While there are concerns about valuation and the market's response to AI developments, sentiments are cautiously optimistic for those willing to view TRI as a long-term investment. Analysts suggest that TRI might be undervalued at its current price, providing an attractive entry point for new investors amidst the prevailing fears.

Consensus

Cautious

Valuation

Fair Value

Similar

RELX, RELX

TOP PICK

Reuters people in England have continued to sell the stock and that has been a real drag. Earnings and dividends are okay. He considers this a multinational stock and the world needs the kind of information systems they have. 3.7% yield.

PAST TOP PICK

(A Top Pick May 20/08. Down 4.51%.) It provides information on financials, legal, accounting and medical. Anticipates growth in earnings because of the cost reductions following the merger.

PAST TOP PICK

(A Top Pick May 29/08. Down 7.9%.) Will have some good surprises in the next year. Still a Buy.

COMMENT

Likes the business model. Global diversified business covering financial services, legal, tax, accounting and scientific/healthcare businesses. 4% dividend yield. Good cash position. Dual listed corporation in London and Toronto and London shares trade at a 10% discount so he would buy it in London.

COMMENT

Several factors on whether you buy Canadian (TRI-T) or US ADR (TRIN-Q). 3.7% yield Canadian but 4.2% in the US. If you have a taxable account you are probably better off buying Canadian.

PAST TOP PICK

(A Top Pick May 8/08. Down 0.71%.) Have come through the environment and are meeting all their targets on cost cutting and synergies. Concerned on losses because of the financial sector.

TOP PICK

(A Top Pick March 2/09.) 4.98% Bond due 2015 and yielding about 5%. Still doing very well. Very solid company.

PAST TOP PICK

(Top Pick Apr 15/08, Down 8.13%) They are strong in legal and scientific and other fields, which benefit them when times are bad. The integration with Reuters went well for them.

PAST TOP PICK

(A Top Pick April 11/08. Down 5.71%.) Held up quite well. Would Buy at $30.

TOP PICK

The Reuters acquisition has turned out very well for them. Quarterly results were quite a bit above expectations. Raised their dividend 4%. An interesting way to participate is through the ADR on NASDAQ (TRIN-Q) (the Reuters portion) as it trades at quite a discount.

PAST TOP PICK

(A Top Pick May 7/08. Down 13%.) Integration and cost cutting of Reuters is going well. Got lumped in with the whole financial crisis selloff. Almost an equal split between legal, educational and healthcare sides. Hoping earnings increase in the next year or so. A Buy. Try to buy on the London exchange (TRIL) as it is trading at about 15% discount.

TOP PICK

Reported great earnings and increased dividends. Reuters’ platform is not directly comparable to Bloomberg's. Much bigger international and commodity exposure. Low risk way of playing recovery in financials. You can purchase this at a 20% discount by buying the ADR on NASDAQ (TRIN-Q) and a good way to get foreign currency exposure.

TOP PICK

4.98% Bond due 2015 and yielding about 5%. Premier company. Doesn't think their financial services will be a problem over that length of time.

PAST TOP PICK

(A Top Pick Feb 28/08. Down 11.3%.) Sold in September at $32+ for a small loss because of exposure on the financial side. Likes the long-term outlook and it could come back at some time.

TOP PICK

People look at this as being very tied to equity markets. Thomson and Reuters gives significant amounts of synergy. Legal software should do well.

Showing 316 to 330 of 718 entries

Most Recent Experts

Brian Madden

First Avenue Investment Counsel

Kim Bolton

Black Swan Dexteritas

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

The Weekly Buzzing Stocks by Billy Kawasaki

Stockchase

Jim Cramer - Mad Money

CNBC

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Thomson Reuters Corp (TRI.TO)